Table 1.
The serogroups and vtx-eae gene characteristics of reported confirmed VTEC serogroups from cases of human infection from 2007–2010 (based on The European Surveillance System data as provided by the European Centre for Disease Prevention and Control)
| Serogroup | Total† | Subtotal‡ | Virulence* characteristics | |||||
|---|---|---|---|---|---|---|---|---|
| eae, vtx1 | eae, vtx2 | eae, vtx1, vtx2 | vtx1 | vtx2 | vtx1, vtx2 | |||
| O157 | 6658 | 5412 | 31 | 3833 | 1530 | 1 | 13 | 4 |
| O26 | 780 | 309 | 205 | 63 | 30 | 9 | 2 | 0 |
| O103 | 370 | 176 | 168 | 4 | 2 | 1 | 1 | 0 |
| O145 | 220 | 108 | 25 | 81 | 1 | 0 | 1 | 0 |
| O91 | 202 | 69 | 0 | 1 | 1 | 35 | 5 | 27 |
| O111 | 134 | 67 | 37 | 13 | 13 | 1 | 2 | 1 |
| O117 | 76 | 64 | 2 | 0 | 1 | 60 | 1 | 0 |
| O146 | 102 | 62 | 0 | 1 | 1 | 3 | 30 | 27 |
| O128 | 108 | 61 | 1 | 7 | 5 | 7 | 19 | 22 |
| O121 | 56 | 49 | 1 | 45 | 1 | 1 | 1 | 0 |
| O113 | 61 | 35 | 0 | 5 | 0 | 2 | 18 | 10 |
| O63 | 55 | 29 | 0 | 25 | 4 | 0 | 0 | 0 |
| O174 | 32 | 23 | 0 | 0 | 0 | 1 | 12 | 10 |
| O156 | 34 | 21 | 6 | 0 | 0 | 13 | 0 | 2 |
| O76 | 34 | 21 | 2 | 0 | 0 | 15 | 1 | 3 |
| O5 | 25 | 18 | 9 | 0 | 1 | 4 | 1 | 3 |
| O55 | 31 | 14 | 3 | 4 | 0 | 7 | 0 | 0 |
| O8 | 20 | 11 | 0 | 2 | 1 | 0 | 7 | 1 |
| O153 | 16 | 11 | 0 | 7 | 0 | 1 | 2 | 1 |
| O84 | 13 | 10 | 8 | 0 | 0 | 0 | 2 | 0 |
| O181 | 12 | 10 | 0 | 0 | 0 | 4 | 0 | 6 |
| Other§ | 450 | 231 | 26 | 51 | 10 | 42 | 80 | 22 |
| NT¶ | 4035 | 467 | 88 | 112 | 41 | 88 | 89 | 49 |
| Total | 13 524 | 7278 | 612 (8·4%) | 4254 (58·5%) | 1642 (22·6%) | 295 (4·1%) | 287 (3·9%) | 188 (2·6%) |
*
eae, Intimin-coding gene; vtx1, verocytotoxin 1 gene; vtx2, verocytotoxin 2 gene.
†
Includes all reported confirmed VTEC cases in humans.
‡
Includes the reported confirmed VTEC cases in humans for which the vtx-eae gene characteristics are reported.
§
Includes other serogroups than already listed. This group includes 83 serogroups.
¶
NT, Untyped/untypable and cases where ‘O’ antigen was reported as unknown.